Essential Blood Tests in Your 30s: A Comprehensive Guide | YEARS

The Most Important Blood Values From Age 30: Which Markers Really Matter

You are in your early 30s, rent or mortgage is paid, your career is going well. You feel healthy, fit, maybe just a little tired sometimes. A comprehensive preventive health check is not on the agenda. After all, the official “Check-up 35” covered by statutory health insurance is still a few years away.

But this is exactly where a central misunderstanding of modern preventive medicine lies.

The course for chronic diseases such as heart attack, stroke, or type 2 diabetes is not set only at 50 or 60, but often much earlier, unnoticed and symptom-free. Standard blood tests, as performed as part of the statutory check-up, capture important risk factors and major abnormalities. However, many subtler, gradual processes that can provide indications of increased risk years earlier are not measured as standard.

This article explains which blood values from age 30 can really be meaningful, what they reveal about your long-term risk profile, and why a more detailed analysis makes sense before the first symptoms appear.

The Standard Program: What the Check-up Measures and What Is Missing

People with statutory health insurance are entitled to a one-time health check-up between the ages of 18 and 34, and every three years from age 35 onward. The program serves the early detection of common widespread diseases and important risk factors, but it is not designed as a comprehensive preventive medical risk analysis.

What the Check-up 35 normally includes:

Blood lipids (lipid profile): Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.

Blood sugar: A fasting blood glucose value to detect signs of diabetes or an increased diabetes risk.

Urine status: Test for protein, glucose, red and white blood cells, and nitrite, as an indication of kidney or urinary tract diseases.

Additionally: Medical history, physical examination, and blood pressure measurement.

This panel detects whether important warning lights are already on or whether central risk factors stand out. A modern preventive approach complements this basis with markers and functional data that can help classify risks earlier, in a more differentiated and individual way.

The Crucial Blood Values From Age 30

To manage your health proactively, you need more than just the basic values. Prevention and longevity research over the past two decades has identified a range of biomarkers that can paint a more precise picture of your risk profile. Here are the most important ones, organized by functional areas.

1. Cardiovascular System

Heart diseases are among the most common causes of death worldwide. Cardiovascular risk usually builds over decades and is often measurable early with the right markers.

Apolipoprotein B (ApoB)

What it is: ApoB is the main protein on atherogenic blood lipid particles such as LDL, VLDL, IDL, and Lp(a). These particles can contribute to the development of atherosclerosis. Most of these particles carry one ApoB-100 molecule each, which allows ApoB to reflect particle number better than the LDL cholesterol value alone.

Why it can be better than LDL: A standard LDL test measures the amount of cholesterol transported, meaning the cargo. ApoB approximately measures the number of atherogenic particles themselves. Two people can have the same LDL value, but a different particle number. Someone with more atherogenic particles can carry a higher risk, even if the LDL value looks unremarkable. The INTERHEART study with over 27,000 participants from 52 countries showed that the ratio of ApoB to ApoA1 is a particularly strong lipid predictor of heart attacks. [Yusuf et al., The Lancet, 2004]

Why you should measure it: Your LDL can be within the normal range, while ApoB already indicates a less favorable particle profile.

Lipoprotein(a) (Lp(a))

What it is: Lp(a) is a predominantly genetically determined blood lipid particle and is considered an independent, causal risk factor for heart attack, stroke, and aortic valve stenosis.

Why it is so critical: Lp(a) can usually only be influenced to a limited extent through lifestyle changes. The value is largely genetically determined. Anyone with a high value should keep an even closer eye on other risk factors such as ApoB, blood pressure, smoking, blood sugar, and inflammation.

Why you should measure it: This value is not measured in the standard check-up. Many people live for decades with this silent risk without knowing it. The European Atherosclerosis Society recommends measuring Lp(a) at least once in a lifetime.

High-sensitivity C-reactive protein (hs-CRP)

What it is: hs-CRP measures low-grade inflammatory activity in the body. It is not a specific disease marker, but it can provide indications of an inflammatory state.

Why it matters: Chronic inflammation can promote atherosclerosis and influence vascular processes. A permanently slightly elevated hs-CRP value is associated in studies with an increased cardiovascular risk, even when cholesterol values appear unremarkable. In the JUPITER study, Ridker et al. showed in 2008 in the New England Journal of Medicine that people with elevated hs-CRP and low LDL-C had fewer cardiovascular events under rosuvastatin. This underlines that inflammatory activity can be relevant in risk assessment.

Why you should measure it: hs-CRP can show whether low-grade inflammatory activity is present in the body. However, the value should always be evaluated in context, since infections, exercise, injuries, chronic diseases, and other factors can influence it.

NT-proBNP

What it is: The heart releases this hormone under mechanical stress or stretching.

Why it matters: An elevated value can be an indication of cardiac strain or heart failure, especially when symptoms, risk factors, or abnormal findings are present. Values below 125 pg/ml are often considered unremarkable in an outpatient context when chronic heart failure is to be ruled out.

Why you should measure it: A normal ECG does not always show whether the heart muscle is under chronic strain. NT-proBNP can provide additional indications, but it should always be interpreted together with blood pressure, symptoms, ECG, echocardiography, and medical assessment.

2. Metabolism

Insulin resistance is an important precursor of type 2 diabetes and one of the most common, yet often underestimated risk factors in the Western world. It develops gradually over years and is associated with cardiovascular diseases, neurodegenerative processes, and certain forms of cancer.

HOMA Index (Homeostasis Model Assessment)

What it is: A calculated value from fasting blood glucose and fasting insulin that provides indications of how well your body’s cells respond to insulin.

Why it can complement fasting glucose: Your body can keep blood sugar within the normal range for years by producing more insulin. Fasting glucose can look unremarkable for a long time, while compensated insulin resistance may already be present. The HOMA index can make this pattern visible earlier than fasting glucose alone.

Why you should measure it: Insulin resistance can often be significantly improved through dietary adjustments, targeted strength and endurance training, and weight management. But only if you know about it.

HbA1c (Hemoglobin A1c)

What it is: HbA1c reflects the average blood sugar level over the past eight to twelve weeks. It measures what percentage of hemoglobin is “sugar-coated.”

Why it is more meaningful than a single value: A single fasting blood glucose value fluctuates depending on sleep, stress, or the previous evening’s meal. HbA1c reflects the pattern over weeks. According to ADA criteria, a value below 5.7% is considered normal; values between 5.7% and 6.4% indicate prediabetes.

Why you should measure it: Together with the HOMA index, it gives a more complete picture of your glucose metabolism. However, the value should be interpreted in context, as iron deficiency, anemia, kidney disease, or changes in red blood cells can influence HbA1c.

3. Nutrients and Hormones

Persistent tiredness, concentration problems, mood swings, hair loss. These symptoms often end up being attributed to “stress” or “too little sleep.” However, measurable deficiencies or hormonal abnormalities can also be behind them.

Ferritin

What it is: The body’s iron storage protein.

Why it is better than the iron value: A normal iron value in the blood can be misleading when stores are already depleted. Ferritin shows the level of these stores much better. Low values are among the common causes of chronic tiredness and reduced performance, especially in women of childbearing age. In practice, they are regularly missed because a blood count without specific suspicion does not include ferritin.

Why you should measure it: Iron deficiency without anemia is a frequently missed cause of tiredness and reduced performance. Ferritin should ideally be evaluated together with CRP, transferrin, and transferrin saturation, since inflammation can increase ferritin and hide a deficiency.

Vitamin D (25-OH Vitamin D)

What it is: Vitamin D is a hormone with effects on bone health, muscle function, and other physiological processes.

Why it is critical: In Germany, insufficient vitamin D supply is widespread, especially in the winter months. According to data from the Robert Koch Institute, around 30% of adults reach values below 30 nmol/l and are therefore considered insufficiently supplied. A deficiency is especially relevant for bone metabolism and muscle function. Connections with immune function and psychological well-being are being studied, but should not be understood as a simple cause-and-effect relationship.

Why you should measure it: Only a measurement can reliably determine your status and enable targeted supplementation.

Thyroid Profile (TSH, fT3, fT4)

What it is: The thyroid regulates the entire body’s basal metabolism. TSH is the control signal from the brain; fT3 and fT4 are the thyroid hormones in the blood.

Why the complete panel can be important: TSH is the central screening value for many thyroid disorders. In case of symptoms, abnormal TSH, known thyroid disease, or specific suspicion, fT4, fT3, and, if needed, thyroid antibodies can provide additional information. This helps better assess whether symptoms such as tiredness, weight gain, or sensitivity to cold could be related to thyroid function.

Why you should measure it: The complete profile of TSH, fT4, and fT3 can provide a more accurate picture of thyroid function than a single value alone in appropriate clinical situations.

The YEARS Principle: From Individual Value to Integrated Strategy

Laboratory values alone are numbers on a sheet of paper. They only develop their meaningfulness in context, combined with further diagnostics and a medical assessment that brings all findings together.

The YEARS Core® Program was developed to close exactly this gap. During a six-hour diagnostics day, a comprehensive baseline of your health is created that goes far beyond a blood panel.

The Core® Program measures over 87 biomarkers as standard, including:

All advanced markers mentioned here: ApoB, hs-CRP, NT-proBNP, HOMA index, HbA1c, ferritin, vitamin D, and the complete thyroid profile (TSH, fT3, fT4).

Combined with functional and imaging diagnostics:

Cardiovascular: 12-lead ECG, detailed heart ultrasound, measurement of arterial stiffness, and ankle-brachial index (ABI).

Lung: Body plethysmography with precise measurement of lung volumes, respiratory mechanics, and performance capacity.

Performance: VO₂max measurement via cardiopulmonary exercise testing, one of the strongest known predictors of long-term health and mortality.

Body composition: 3D body scan and bioelectrical impedance analysis for a more precise assessment of muscle, fat, and body compartments.

Early detection: AI-supported skin screening and AI funduscopy to look for early signs of disease in the skin and retina.

Two weeks after the diagnostics day, the strategy consultation follows. A doctor from the YEARS team explains the results in detail, shows connections, and prioritizes your personal risks. You do not go home with a lab sheet, but with a clear, medically grounded plan.

Frequently Asked Questions

How often should you check your blood values from age 30?

That depends on your baseline values and risk factors. A comprehensive baseline measurement, as offered by the YEARS Core® Program, is a sensible starting point in your thirties. For healthy people without special risks, an update every two to three years is sufficient. If risks are identified, an annual check can make sense.

Does my health insurance cover the costs?

Statutory health insurance covers the check-up from age 35 every three years. Extended markers such as ApoB, Lp(a), or HOMA index are usually billed privately as individual health services. YEARS bills according to the German medical fee schedule (GOÄ). Possible reimbursement by private health insurance depends on the respective tariff, medical justification, and individual assessment by the insurer. It is best to clarify the exact details with your own insurance provider in advance. More information is available in our FAQ.

What is the difference between “normal” and “optimal” values?

The reference ranges on lab sheets usually show whether a value lies outside a statistically or clinically defined range. For some markers, there are also risk-associated target ranges, for example for LDL-C, ApoB, blood pressure, or HbA1c. The YEARS medical team evaluates results not just according to “normal,” but in the context of your personal risk profile, your medical history, your symptoms, and your health goals.

Is a blood test from an online provider not enough?

As a first indication, a pure blood test can be helpful. Without the context of further examinations such as ultrasound or performance diagnostics and without in-depth medical interpretation, they remain data points that are difficult to classify. Prevention arises from synthesizing all information into a coherent strategy.

Take Your Health Into Your Own Hands

In your thirties, you can lay the foundation for the next decades. Anyone who waits until the first symptoms appear loses the most valuable period for preventive interventions. An extended blood panel with markers such as ApoB, Lp(a), hs-CRP, and HOMA index provides the basis for managing risks in a targeted way before they become manifest.

Book a non-binding consultation now or find out more about the YEARS Core® Program.

Sources

Gemeinsamer Bundesausschuss (G-BA). Gesundheitsuntersuchungs-Richtlinie. Stand: 19. Juli 2018. Available at: https://www.g-ba.de/richtlinien/18/

Bundesministerium für Gesundheit (BMG). Der Gesundheits-Check-up. Available at: https://www.bundesgesundheitsministerium.de/checkup.html

Kassenärztliche Bundesvereinigung (KBV). Gesundheitsuntersuchung (Check-up). Available at: https://www.kbv.de/html/gesundheitsuntersuchung.php

Mach, F., et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 41(1), 111-188. doi:10.1093/eurheartj/ehz455

Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., et al. (2022). Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: A European Atherosclerosis Society consensus statement. European Heart Journal, 43(39), 3925-3946. doi:10.1093/eurheartj/ehac361

Januzzi Jr, J. L., et al. (2018). NT-proBNP for Diagnosis and Prognosis in Heart Failure. Heart Failure Clinics, 14(4), 459-470. doi:10.1016/j.hfc.2018.06.002

McDonagh, T. A., et al. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 3599-3726. doi:10.1093/eurheartj/ehab368

American Diabetes Association (ADA). Standards of Care in Diabetes. Diabetes Care.

RKI (Robert Koch-Institut). (2016). Vitamin-D-Mangel und die Folgen – wie verbreitet ist das Problem wirklich? Journal of Health Monitoring, 1(2). doi:10.17886/RKI-GBE-2016-036

Ridker, P. M., et al. (2008). Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine, 359(21), 2195-2207. doi:10.1056/NEJMoa0807646

Yusuf, S., et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937-952. doi:10.1016/S0140-6736(04)17018-9

Mandsager, K., Harb, S., Cremer, P., Phelan, D., Nissen, S. E., & Jaber, W. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open, 1(6), e183605. doi:10.1001/jamanetworkopen.2018.3605

This article is for general information and does not replace individual medical advice. The programs and examinations described are preventive medical services and not treatment for acute or chronic diseases.